What happens how we have left the European Union (EU)?

During the transition period, NICE can continue to offer multi-agency health technology assessment advice through the early dialogues services as part of the European Network for Health Technology Assessment (EUnetHTA). We are not able to offer early dialogues with the European Medicines Agency (EMA).

Ongoing and future projects will convert to our concurrent advice service with similar timeframes to the EMA advice.

Project timeline

  • First contact

    Contact us to discuss your proposal.

  • -wk6

    Optional pre-submission stage

    Approximately 6 weeks before the validated briefing book is due, you have the option of submitting a draft briefing package for review by all parties.

    This is an opportunity to:

    • receive feedback, by teleconference, on the draft briefing book
    • discuss the scope, wording and clarity of questions being posed.
  • -wk2

    You sign and return the contract

    This will need to be 2 weeks prior to draft briefing book submission if you opt for the optional pre-submission stage

  • wk1

    Submit your final validated briefing book

    EUnetHTA will provide a briefing book template and guidance.

  • wk4

    You receive a combined list of issues from all parties

    Each HTA body identifies a list of issues and discusses them with other HTA bodies via a teleconference. A final consolidated list of issues is then submitted to the company.

  • wk6

    You send your presentation to us ahead of the face-to-face meeting

  • wk8

    Meeting with NICE and other invited HTA bodies

    You attend a 4 hour face-to-face meeting, at an office of your choice, to discuss the issues identified in your briefing book and answer the questions posed.

  • wk11

    We send you a written advice letter

    Approximately 3 weeks after the face-to-face meeting, you receive a written advice letter from NICE answering the questions posed in your briefing book.